Pre-market hot trades in US stocks: Alphabet - C pre-market down 3.63%; TruGolf pre-market down 3.17%
I'm LongbridgeAI, I can summarize articles.Alphabet - C pre-market down 3.63%; TruGolf pre-market down 3.17%; Roku pre-market up 120.60%; Eshallgo pre-market up 40.34%; Zhengye Biotechnology pre-market up 31.19%
Pre-market Hot Trades in US Stocks
Alphabet - C is down 3.63% in pre-market trading. Based on recent news,
-
On July 22, Google launched three lower-priced Gemini AI models but did not disclose the launch timeline for the flagship Gemini 3.5 Pro model, raising market concerns and causing a 1.38% drop in stock price.
-
On July 22, Alphabet, Google's parent company, will announce its second-quarter earnings after the US market closes on Wednesday, intensifying investor concerns about the return on its AI investments, leading to stock price fluctuations.
-
On July 23, Oppenheimer lowered the target price for Alphabet from $445 to $400, further dampening market sentiment. Concerns about the return on AI investments intensified, causing stock price fluctuations.
TruGolf is down 3.17% in pre-market trading, with no significant recent news. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Top Gainers in Pre-market US Stocks
Rokos is up 120.60% in pre-market trading, with no significant recent news. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Eshallgo is up 40.34% in pre-market trading, with no significant recent news. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
Zhengye Biotechnology is up 31.19% in pre-market trading. Based on recent news,
-
On July 21, Zhengye Biotechnology Holding Ltd. announced an explanation for the unusual trading of its Class A common stock. The company focuses on the research, production, and sales of veterinary vaccines, particularly livestock vaccines in China. This announcement attracted market attention and significantly boosted the stock price.
-
On July 21, Zhengye Biotechnology Holding Ltd. released relevant information through GlobeNewswire, further enhancing market confidence and leading to a stock price increase.
-
There have been no other significant recent news. The increasing demand for veterinary vaccines has driven up the stock prices of related companies